TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10690132

Group type: EXPERIMENTAL
Intervention: Omitting ACE inhibitor medication before surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Continuing ACE inhibitor medication before surgery
Number of subjects: 40
Study: 9229859

Group type: EXPERIMENTAL
Intervention: Free gamma-aminobutyric acid and other neuroactive amino acids in cerebrospinal fluid (CSF)
Number of subjects: 64
Study: 1984377

Group type: EXPERIMENTAL
Intervention: 4 mg epidural morphine with 3 mL of normal saline (group 1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4 mg epidural morphine with 1 mg butorphanol and 2 mL of normal saline (group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4 mg epidural morphine with 3 mg butorphanol (group 3)
Number of subjects: 30
Study: 330287

Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 40
Study: 30414785

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (treadmill at 60% of maximum volume of oxygen utilization)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Resistance training (8 to 12 repetitions of 5 upper and lower body exercises at 60% to 80% of 1 repetition maximum)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 10
Study: 28181773

Group type: EXPERIMENTAL
Intervention: Fitbit Charge HR (FIT)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Pedometer (PED)
Number of subjects: 17
Study: 25087057

Group type: EXPERIMENTAL
Intervention: Droperidol (75 mcg/kg) administered after cardiopulmonary bypass
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Volatile anesthesia
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Postoperative QTc
Number of subjects: 62
Study: 23474908

Group type: EXPERIMENTAL
Intervention: Ticagrelor with low-dose acetylsalicylic acid (ASA) (≤150 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel with low-dose acetylsalicylic acid (ASA) (≤150 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 21704242

Group type: EXPERIMENTAL
Intervention: Etamicastat 100 mg single dose
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Etamicastat 100 mg/day for 7 days
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Etamicastat single dose
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Etamicastat steady state
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Etamicastat
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 25
Study: 19428083

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg/d orally for 3 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 22832975

Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 100
Study: 15948098

Group type: EXPERIMENTAL
Intervention: Measurements of N-terminal pro-brain natriuretic peptide (NT-proBNP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provision of plasma BNP data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serial measurements of NT-proBNP
Number of subjects: 0
Study: 12841537

Group type: EXPERIMENTAL
Intervention: Insulin (I)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PCO-like group
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: MFO group
Number of subjects: 25
Study: 10464870

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) in an inhaler containing hydrofluoroalkane (HFA) propellant, Qvar®
Number of subjects: 0
Study: 8553087

Group type: EXPERIMENTAL
Intervention: Venous platelet count (VPC) in LPC
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Capillary platelet count (CPC) in LPC
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Venous platelet count (VPC) in NPC
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Capillary platelet count (CPC) in NPC
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Reproducibility of counts in LPC
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Reproducibility of counts in NPC
Number of subjects: 35

Group type: COMPARATOR
Intervention: Overall comparison of VPC and CPC
Number of subjects: 35
Study: 2693691

Group type: EXPERIMENTAL
Intervention: Hydroxypropyl methylcellulose 2% (Adatocel)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyaluronic acid 1% (Healon)
Number of subjects: 0
Study: 754379

Group type: EXPERIMENTAL
Intervention: E-Test
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: Letter-Matching-Test
Number of subjects: 633
Study: 12426514

Group type: EXPERIMENTAL
Intervention: Rifampin 600 mg orally once daily for 5 days (phase 2)
Number of subjects: 10
Study: 30071058

Group type: EXPERIMENTAL
Intervention: High-polluted area
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-polluted area
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control area
Number of subjects: 0
Study: 26876527

Group type: EXPERIMENTAL
Intervention: Task-Oriented Training (TOT) with EMG-stimulation for 30 minutes per day, 5 days per week, for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: EMG-stimulation for 20 minutes per day, 5 days per week, for 4 weeks
Number of subjects: 20
Study: 23904065

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone (11 infants)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (11 infants)
Number of subjects: 22
Study: 23276234

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support + treatment as usual
Number of subjects: 41

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 41
Study: 20189226

Group type: EXPERIMENTAL
Intervention: Doxazosin (2 mg daily at night) along with diclofenac sodium 50 mg
Number of subjects: 65

Group type: COMPARATOR
Intervention: Diclofenac sodium 50 mg
Number of subjects: 65
Study: 18080951

Group type: EXPERIMENTAL
Intervention: Repeated-sprint training group (RSG, 3 x 6 maximal shuttle sprints of 40 m)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Interval training group (ITG, 4 x 4 min running at 90 - 95 % of HRmax)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 16146478

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of bupivacaine (20 ml of 2.5 mg/ml) 30 min before skin incision
Number of subjects: 40

Group type: COMPARATOR
Intervention: Post-operative administration of bupivacaine (20 ml of 2.5 mg/ml) after skin closure
Number of subjects: 40
Study: 12182256

Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate 1%/benzoyl peroxide 5% gel formulation
Number of subjects: 79

Group type: COMPARATOR
Intervention: Clindamycin 1% gel (monotherapy)
Number of subjects: 79
Study: 10202871

Group type: EXPERIMENTAL
Intervention: 100 mg of clomiphene citrate on days 1-5 and placebo on days 5-9
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo on days 1-5 and clomiphene citrate on days 5-9
Number of subjects: 23
Study: 8539022

Group type: EXPERIMENTAL
Intervention: Dapiprazole 0.5% ophthalmic solution
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 2222553

Group type: COMPARATOR
Intervention: Placebo formulations (i.v. solution; p.o. solution; p.o. solid forms)
Number of subjects: 0

Group type: COMPARATOR
Intervention: H1-antagonist positive control
Number of subjects: 0
Study: 750663

Group type: EXPERIMENTAL
Intervention: Irregular temporal pulse patterns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular temporal pulse patterns
Number of subjects: 0
Study: 30471795

Group type: EXPERIMENTAL
Intervention: Andalusian aged wine (AAW)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: gin
Number of subjects: 41
Study: 28274900

Group type: EXPERIMENTAL
Intervention: Melatonin (Group B)
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: Melatonin, tryptophan, and vitamin B6 (Group C)
Number of subjects: 748

Group type: COMPARATOR
Intervention: Placebo (Group A)
Number of subjects: 748
Study: 25592855

Group type: EXPERIMENTAL
Intervention: Rituximab (375 mg/m2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Prednisone alone)
Number of subjects: 30
Study: 23488984

Group type: EXPERIMENTAL
Intervention: Surgical evacuation
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Medical evacuation
Number of subjects: 180

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 180
Study: 21525521

Group type: EXPERIMENTAL
Intervention: Early screening for suicidal ideation
Number of subjects: 443

Group type: COMPARATOR
Intervention: Delayed screening (control)
Number of subjects: 443
Study: 19210298

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 30 mg
Number of subjects: 445

Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 60 mg
Number of subjects: 445

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study: 16626426

Group type: EXPERIMENTAL
Intervention: Chloroquine diphosphate
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 34
Study: 12972527

Group type: EXPERIMENTAL
Intervention: Health-related quality of life (HRQOL) evaluation in treatment arms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional clinical endpoints
Number of subjects: 0

Group type: COMPARATOR
Intervention: Overall survival
Number of subjects: 0
Study: 11096166

Group type: EXPERIMENTAL
Intervention: Infliximab plus methotrexate
Number of subjects: 428

Group type: COMPARATOR
Intervention: Methotrexate alone
Number of subjects: 428
Study: 8924098

Group type: EXPERIMENTAL
Intervention: Nurse-midwifery care
Number of subjects: 194

Group type: COMPARATOR
Intervention: Standard care (physician group)
Number of subjects: 194
Study: 1560166

Group type: EXPERIMENTAL
Intervention: Dietary fish oil supplementation (3.2 gm/day of eicosapentaenoic acid and 2.2 gm/day of docosahexaenoic acid) for 10 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo olive oil for 10 weeks
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both fish oil and placebo
Number of subjects: 16
Study: 4062052

Group type: EXPERIMENTAL
Intervention: 4% lidocaine plus decongestant
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (decongestant plus saline)
Number of subjects: 10
Study: 30809788

Group type: EXPERIMENTAL
Intervention: Endoscopic screening with chromoendoscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional screening (protocol-driven costs excluded)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulated 10-year screening project
Number of subjects: 0
Study: 30466597

Group type: EXPERIMENTAL
Intervention: Nitrate re-supply treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrate starvation treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrate treatments (combined starvation and re-supply)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Validation of differentially expressed genes
Number of subjects: 0
Study: 27044367

Group type: EXPERIMENTAL
Intervention: Electronic clinical decision‐support tool
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3000
Study: 25047415

Group type: EXPERIMENTAL
Intervention: Multiplex nested PCR
Number of subjects: 54

Group type: COMPARATOR
Intervention: Blood cultures
Number of subjects: 54
Study: 22154338

Group type: EXPERIMENTAL
Intervention: Self-report measures, Behavioral Approach Test (BAT), physiological reactivity
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Behavioral Approach Test (BAT)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Gender role orientation (instrumentality)
Number of subjects: 144
Study: 20202235

Group type: EXPERIMENTAL
Intervention: Intramuscular diclofenac 75 mg at the end of the operation followed by 75 mg for 24 hours (150 mg/24 h)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intravenous paracetamol 1g/100 mL twice daily as postoperative analgesia
Number of subjects: 50
Study: 18018837

Group type: COMPARATOR
Intervention: Halothane 1 ml, Isoflurane 1.5 ml, Sevoflurane 2.7 ml (experiment 1)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Halothane 2, 4, and 6 ml (experiment 2)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Sevoflurane 5 ml (experiment 3)
Number of subjects: 70
Study: 16170943

Group type: EXPERIMENTAL
Intervention: Time tunnel display
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline configural display
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trend display
Number of subjects: 0
Study: 12038495

Group type: EXPERIMENTAL
Intervention: Presence of 4 spelling errors in a short essay
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Large number of spelling errors in a short essay
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misspellings made by writers in a short essay
Number of subjects: 0
Study: 10844630

Group type: EXPERIMENTAL
Intervention: 10% TPD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25% TPD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50% TPD
Number of subjects: 0

Group type: COMPARATOR
Intervention: APD (Group I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25% TPD (Group II)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50% TPD (Group II)
Number of subjects: 0

Group type: COMPARATOR
Intervention: APD (Group II)
Number of subjects: 0
Study: 9279669

Group type: EXPERIMENTAL
Intervention: Hydrophobic IOLs (specific types not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrophilic IOLs (specific types not detailed)
Number of subjects: 0
Study: 2054701

Group type: EXPERIMENTAL
Intervention: Midazolam (0.3 to 0.5 mg/kg) combined with atropine sulfate (0.015 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (injectable water) combined with atropine sulfate (0.015 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 6356966

Group type: EXPERIMENTAL
Intervention: Terbutaline inhalations (31 + 31 + 63 + 125 + 250 micrograms) from a pressurized aerosol with a 750 ml spacer
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as part of the double-blind design)
Number of subjects: 12
Study: 31726485

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure
Number of subjects: 1101

Group type: COMPARATOR
Intervention: Sham continuous positive airway pressure
Number of subjects: 1101
Study: 30999058

Group type: EXPERIMENTAL
Intervention: Tailored smoking-cessation intervention delivered 100% through text messaging (TMQ)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-smoking-related text messages (Mojo)
Number of subjects: 0
Study: 28137609

Group type: EXPERIMENTAL
Intervention: Dietary nitrate load (300 mg) by highly concentrated beetroot juice (BJ)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 17
Study: 25869625

Group type: EXPERIMENTAL
Intervention: Diabetes Remote Monitoring and Management System (DRMS)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 98
Study: 23131174

Group type: EXPERIMENTAL
Intervention: Nintendo® Wii Balance Board exercises (Group A)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group with only two elected exercises (Group B)
Number of subjects: 71
Study: 21397780

Group type: COMPARATOR
Intervention: 400-mg rufinamide tablet (reference)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10 mL of rufinamide suspension (40 mg/mL) at 1800 rpm
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10 mL of rufinamide suspension (40 mg/mL) at 2100 rpm
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10 mL of rufinamide suspension (40 mg/mL) at 3000 rpm
Number of subjects: 24
Study: 18444817

Group type: COMPARATOR
Intervention: 1.5 g of cefuroxime 10‐30 min before inflation of the tourniquet and placebo 10 min before release of the tourniquet (standard arm)
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: Placebo 10‐30 min before inflation of the tourniquet and 1.5 g of cefuroxime 10 min before release of the tourniquet (experimental arm)
Number of subjects: 908
Study: 16557208

Group type: EXPERIMENTAL
Intervention: 99mTc‐MIBI brain SPECT and proton magnetic resonance spectroscopy (1H‐MRS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 99mTc‐MIBI brain SPECT
Number of subjects: 30
Study: 15724755

Group type: EXPERIMENTAL
Intervention: Concise Light Cured White Sealant applied without vibration
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Concise Light Cured White Sealant applied with vibration
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single Bond Adhesive applied, then Concise Light Cured White Sealant applied without vibration
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Single Bond Adhesive applied, then Concise Light Cured White Sealant applied with vibration
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Concise Light Cured White Sealant applied without vibration, then Z‐100 composite burnished over sealant and light‐cured
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Concise Light Cured White Sealant applied with vibration, then Z‐100 composite burnished over sealant and light‐cured
Number of subjects: 36
Study: 11097670

Group type: COMPARATOR
Intervention: Needle only
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% with dexamethasone 0.13 mg/mL
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% with dexamethasone 0.13 mg/mL
Number of subjects: 30
Study: 9315064

Group type: EXPERIMENTAL
Intervention: Primary therapy with tamoxifen alone (n=160)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Mastectomy and postoperative tamoxifen (n=53)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Primary surgery (104 mastectomy; 27 wide local excision) without adjuvant tamoxifen (n=131)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Regional relapse treated with surgery, radiotherapy or endocrine manipulation
Number of subjects: 184
Study: 8336864

Group type: EXPERIMENTAL
Intervention: Zoladex (goserelin acetate), 3.6 mg every 28 days by subcutaneous injection
Number of subjects: 315

Group type: COMPARATOR
Intervention: Danazol, 400 mg orally twice daily for 24 weeks
Number of subjects: 315
Study: 3528119

Group type: EXPERIMENTAL
Intervention: Choledyl SA
Number of subjects: 10

Group type: COMPARATOR
Intervention: Theo-Dur
Number of subjects: 10
Study: 3276422

Group type: COMPARATOR
Intervention: Standard ligament release alone
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Adjunctive interfascicular neurolysis
Number of subjects: 50
Study: 29689693

Group type: EXPERIMENTAL
Intervention: Vortioxetine (10 or 20mg)
Number of subjects: 602

Group type: COMPARATOR
Intervention: Duloxetine (60mg)
Number of subjects: 602

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 602
Study: 28057058

Group type: EXPERIMENTAL
Intervention: Lian-Ju-Gan-Mao capsules (LJGMC) high-dose group
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Lian-Ju-Gan-Mao capsules (LJGMC) medium-dose group
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Lian-Ju-Gan-Mao capsules (LJGMC) low-dose group
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo-matched group
Number of subjects: 240
Study: 26203738

Group type: EXPERIMENTAL
Intervention: Fingerboarding (FB)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Bouldering (BL)
Number of subjects: 23
Study: 23987903

Group type: EXPERIMENTAL
Intervention: Minimally invasive esophagectomy
Number of subjects: 114

Group type: COMPARATOR
Intervention: Open esophagectomy
Number of subjects: 114
Study: 21050796

Group type: EXPERIMENTAL
Intervention: Regular sunlight exposure (3231 min/year)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Usual lifestyle
Number of subjects: 324
Study: 18697849

Group type: EXPERIMENTAL
Intervention: Hip protectors worn on either the right or left hip
Number of subjects: 580

Group type: COMPARATOR
Intervention: Control group (no hip protectors)
Number of subjects: 580
Study: 16596114

Group type: EXPERIMENTAL
Intervention: Exercise (EX): 1 hour of cycling at 63.1+/‐6% VO2peak (TRI) and 61+/‐5.1% VO2peak (REC)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Rest (RE): 1 hour of sitting
Number of subjects: 14
Study: 15587400

Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional IVF
Number of subjects: 32

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 32
Study: 12575402

Group type: EXPERIMENTAL
Intervention: Shenkang injection (SKI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Benazepril
Number of subjects: 0
Study: 9260237

Group type: EXPERIMENTAL
Intervention: Deflazacort (DFZ)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prednisone (PDN)
Number of subjects: 40
Study: 7984593

Group type: EXPERIMENTAL
Intervention: Adjuvant endovascular irradiation of blood with He‐Ne laser (8-10 daily sessions lasting 30 minutes)
Number of subjects: 48
Study: 3104873

Group type: EXPERIMENTAL
Intervention: Doubly labeled water (DLW)
Number of subjects: 9

Group type: COMPARATOR
Intervention: RGE (Respiratory Gas Exchange)
Number of subjects: 9
Study: 29119483

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 66
Study: 29916668

Group type: EXPERIMENTAL
Intervention: Maylard incision
Number of subjects: 81

Group type: COMPARATOR
Intervention: Pfannenstiel incision
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study: 24600214

Group type: EXPERIMENTAL
Intervention: Peripheral nerve blocks (PNBs) with propofol sedation
Number of subjects: 213

Group type: COMPARATOR
Intervention: General anesthesia with combined propofol and remifentanil
Number of subjects: 213
Study: 22715910

Group type: EXPERIMENTAL
Intervention: Knowledge and community educational videos (scientific vs. colloquial)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Pictorial pamphlet
Number of subjects: 92
Study: 20435291

Group type: EXPERIMENTAL
Intervention: Soy supplementation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Casein placebo
Number of subjects: 39
Study: 18603505

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (50 micrograms every 4 hours for a maximum of four doses)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (conservative management)
Number of subjects: 84